These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 5072718)

  • 1. Implications of amphetamine-induced stereotyped behavior as a model for tardive dyskinesias.
    Rubovits R; Klawans HL
    Arch Gen Psychiatry; 1972 Oct; 27(4):502-7. PubMed ID: 5072718
    [No Abstract]   [Full Text] [Related]  

  • 2. The pharmacology of tardive dyskinesias.
    Klawans HL
    Am J Psychiatry; 1973 Jan; 130(1):82-6. PubMed ID: 4264755
    [No Abstract]   [Full Text] [Related]  

  • 3. [The antipsychotic action of neuroleptics and basal ganglia function].
    Arushanian EB
    Farmakol Toksikol; 1973; 26(4):481-9. PubMed ID: 4151298
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathophysiology of schizophrenia and the striatum.
    Klawans HL; Goetz C; Westheimer R
    Dis Nerv Syst; 1972 Nov; 33(11):711-9. PubMed ID: 4266033
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic approaches to tardive dyskinesia. A review of the literature.
    Kazamatsuri H; Chien C; Cole JO
    Arch Gen Psychiatry; 1972 Oct; 27(4):491-9. PubMed ID: 4116201
    [No Abstract]   [Full Text] [Related]  

  • 6. Mescaline: receptor interaction in the rat striatum.
    Dill RE
    Arch Int Pharmacodyn Ther; 1972 Feb; 195(2):320-9. PubMed ID: 4335683
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine.
    Kazamatsuri H; Chien C; Cole JO
    Arch Gen Psychiatry; 1972 Jul; 27(1):95-9. PubMed ID: 4555831
    [No Abstract]   [Full Text] [Related]  

  • 8. A dopaminergic-cholinergic mechanism in production of psychotic symptoms.
    Friedhoff AJ; Alpert M
    Biol Psychiatry; 1973 Apr; 6(2):165-9. PubMed ID: 4709131
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.
    Kazamatsuri H; Chien C; Cole JO
    Arch Gen Psychiatry; 1972 Jul; 27(1):100-3. PubMed ID: 4555826
    [No Abstract]   [Full Text] [Related]  

  • 10. Tardive dyskinesia.
    Simpson GM
    Br J Psychiatry; 1973 May; 122(570):618. PubMed ID: 4717040
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prolonged neurologic syndromes due to neuroleptic drugs and their treatment].
    Deniker P; Ginestet D
    Ann Med Interne (Paris); 1972; 123(8):787-9. PubMed ID: 4642195
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chronic facio-lingual dyskinesia in patients treated with neuroleptics].
    Gralewski Z
    Neurol Neurochir Pol; 1973; 7(3):393-8. PubMed ID: 4714195
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cellular effect of neuroleptics].
    Kuschinsky K
    Dtsch Med Wochenschr; 1975 Jun; 100(25):1405-8. PubMed ID: 237751
    [No Abstract]   [Full Text] [Related]  

  • 14. Dissociation of stereotyped biting responses and oro-bucco-lingual dyskinesias.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1976 Apr; 36(2):423-9. PubMed ID: 945168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stereotyped behavior and late chronic dyskinesias: role of anticholinergic drugs].
    Casacchia M; Cerbo R; Carchedia F; Meco G; Carolei A
    Boll Soc Ital Biol Sper; 1976 Feb; 52(4):251-4. PubMed ID: 986146
    [No Abstract]   [Full Text] [Related]  

  • 16. An experimental model of tardive dyskinesia.
    Klawans HL; Rubovits R
    J Neural Transm; 1972; 33(3):235-46. PubMed ID: 4674512
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention and management of tardive dyskinesia.
    Crane GE
    Am J Psychiatry; 1972 Oct; 129(4):466-7. PubMed ID: 5071149
    [No Abstract]   [Full Text] [Related]  

  • 18. [Extrapyramidal symptoms following Clozapine therapy. Case report].
    Doepp S; Buddeberg C
    Nervenarzt; 1975 Oct; 46(10):589-90. PubMed ID: 811999
    [No Abstract]   [Full Text] [Related]  

  • 19. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.
    Andén NE; Butcher SG; Corrodi H; Fuxe K; Ungerstedt U
    Eur J Pharmacol; 1970; 11(3):303-14. PubMed ID: 5477307
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuroleptic antagonism of dyskinetic phenomena.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1975; 33(2):301-12. PubMed ID: 241654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.